收费全文 | 2417篇 |
免费 | 147篇 |
国内免费 | 8篇 |
耳鼻咽喉 | 28篇 |
儿科学 | 82篇 |
妇产科学 | 104篇 |
基础医学 | 379篇 |
口腔科学 | 49篇 |
临床医学 | 303篇 |
内科学 | 378篇 |
皮肤病学 | 29篇 |
神经病学 | 315篇 |
特种医学 | 73篇 |
外科学 | 170篇 |
综合类 | 8篇 |
一般理论 | 2篇 |
预防医学 | 236篇 |
眼科学 | 34篇 |
药学 | 184篇 |
中国医学 | 8篇 |
肿瘤学 | 190篇 |
2023年 | 20篇 |
2022年 | 64篇 |
2021年 | 108篇 |
2020年 | 79篇 |
2019年 | 64篇 |
2018年 | 95篇 |
2017年 | 63篇 |
2016年 | 72篇 |
2015年 | 74篇 |
2014年 | 100篇 |
2013年 | 169篇 |
2012年 | 185篇 |
2011年 | 206篇 |
2010年 | 96篇 |
2009年 | 80篇 |
2008年 | 146篇 |
2007年 | 140篇 |
2006年 | 146篇 |
2005年 | 146篇 |
2004年 | 109篇 |
2003年 | 95篇 |
2002年 | 86篇 |
2001年 | 16篇 |
2000年 | 8篇 |
1999年 | 10篇 |
1998年 | 14篇 |
1997年 | 14篇 |
1996年 | 12篇 |
1995年 | 6篇 |
1994年 | 4篇 |
1992年 | 6篇 |
1991年 | 9篇 |
1990年 | 8篇 |
1988年 | 10篇 |
1987年 | 10篇 |
1986年 | 5篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 6篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 3篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1973年 | 11篇 |
1972年 | 10篇 |
1971年 | 3篇 |
1970年 | 4篇 |
Purpose
The maintaining of asthma control is difficult due to high variability in response to therapy among patients. Since matrix metalloproteinase 9 (MMP9) is implicated in inflammation and remodeling of asthmatic airways, it could be associated with adequate response to asthma therapy. The aim of this study was to investigate whether variants in 3′ end of the MMP9 gene are associated with clinical phenotype and responsiveness to treatment in children with asthma.Methods
The study included 127 asthmatic children from Slovenia. Variants in the 3′ end of the MMP9 gene were analyzed by direct DNA sequencing and the obtained results were correlated with clinical parameters.Results
Two variants were detected, rs13925 and rs20544. For the variant rs20544, statistically significant difference in airway hyperresponsiveness (p?=?0.011) and asthma control (p?=?0.049) between genotypes was found. Patients with TT genotype had lower airway sensitivity, and after 12 months of treatment showed significant improvement in Asthma Control Test (ACT) scores compared to CC and CT genotype. For the variant rs13925, the association with lung function was observed. The carriers of A allele showed noticeable improvement of lung function after the first 6 months of treatment in comparison to the carriers of G allele (p?=?0.046).Conclusion
The main finding of our study is the association of MMP9 genotypes rs20544 TT and rs13925 AA and AG with better asthma control, and indirectly better response to treatment. Based on these results, MMP9 deserves further research as a potential predictive biomarker for asthma.Currently, multiple myeloma (MM) is an incurable disease. Despite the fact that arsenic trioxide (ATO) shows promising results in vitro, data from treatment of patients with MM are disappointing. Due to these discrepancies, we compared the efficacy and selectivity of ATO at two different concentrations in samples from MM patients.
Methods
The extent of apoptosis induced by 2 and 5 µM ATO was evaluated by flow cytometry using annexin V. 34 diagnostic bone marrow samples obtained from MM patients were analysed.
Results
5 µM ATO efficiently induced apoptosis in primary samples. Besides efficacy, also selectivity of action on MM cells in comparison to remaining haematopoietic cells was demonstrated for 5 µM ATO but not for 2 µM ATO.
Discussion
Our study on primary samples confirmed that ATO has a potential role in therapeutic management of MM. Further controlled studies on MM patients are needed. 相似文献